[1] Anderson G.G., Dodson K.W., Hooton T.M.,
Hultgren S.J., Intracellular bacterial communities of
uropathogenic Escherichia coli in urinary tract pathogenesis,
Trends Microbiol. (2004) 12:424–430.
[2] Bannerman D.D., Paape M.J., Lee J.W., Zhao X.,
Hope J.C., Rainard P., Escherichia coli and Staphylococcus
aureus elicit differential innate immune responses
following intramammary infection, Clin. Diagn. Lab.
Immunol. (2004) 11:463–472.
[3] Bannerman D.D., Paape M.J., Hare W.R., Hope J.C.,
Characterization of the bovine innate immune response to
intramammary infection with Klebsiella pneumoniae,
J. Dairy Sci. (2004) 87:2420–2432.
[4] Bannerman D.D., Pathogen-dependent induction of
cytokines and other soluble inflammatory mediators
during intramammary infection of dairy cows, J. Anim.
Sci. (2008) 87:10–25.
[5] Barkema H.W., Schukken Y.H., Lam T.J.G.M.,
Beiboer M.L., Wilmink H., Benedictus G., Brand A.,
Incidence of clinical mastitis in dairy herds grouped in
three categories by bulk milk somatic cell counts, J. Dairy
Sci. (1998) 81:411–419.
[6] Bergsten G., Wullt B., Svanborg C., Escherichia coli,
fimbriae, bacterial persistence and host response induction
in the human urinary tract, Int. J. Med. Microbiol. (2005)
295:487–502.
[7] Berry R.E., Klumpp D.J., Schaeffer A.J., Urothelial
cultures support intracellular bacterial community formation
by uropathogenic Escherichia coli, Infect. Immun.
(2009) 77:2762–2772.
[8] Burvenich C., Van Merris V., Mehrzad J., Diez-Fraile
A., Duchateau L., Severity of E. coli mastitis is mainly
determined by cow factors, Vet. Res. (2003) 34:521–564.
[9] Burvenich C., Monfardini E., Mehrzad J., Capuco
A.V., Paape M.J., Role of neutrophil polymorphonuclear
leukocytes during bovine coliform mastitis: physiology or
pathology?, Verh. K. Acad. Geneeskd. Belg. (2004)
66:97–150.
[10] Detilleux J., Vangroenweghe F., Burvenich C.,
Mathematical model of the acute inflammatory response
to Escherichia coli in intramammary challenge, J. Dairy
Sci. (2006) 89:3455–3465.
[11] Dogan B., Klaessig S., Rishniw M., Almeida R.,
Oliver S.P., Simpson K.W., Schukken Y.H., Adherent and
Invasive Escherichia coli are associated with persistent
bovine mastitis, Vet. Microbiol. (2006) 116:270–282.
[12] Do¨pfer D., Barkema H.W., Lam T.J.G.M., Schukken
Y.H., Gaastra W., Recurrent clinical mastitis caused by
Escherichia coli in dairy cows, J. Dairy Sci. (1999)
82:80–85.
[13] Dosogne H., Vangroenweghe F., Mehrzad J.,
Massart-Leen A.M., Burvenich C., Differential leukocyte
count method for bovine low somatic cell count milk,
J. Dairy Sci. (2003) 86:828–834.
[14] Franco A.V., Recurrent urinary tract infections, Best
Pract. Res. Clin. Obstet. Gynaecol. (2005) 19:861–873.
[15] Green M.J., Green L.E., Medley G.F., Schukken
Y.H., Bradley A.J., Influence of dry period bacterial
intramammary infection on clinical mastitis in dairy cows,
J. Dairy Sci. (2002) 85:2589–2599.
[16] Iwahi T., Imada A., Interaction of Escherichia coli
with polymorphonuclear leukocytes in pathogenesis of
urinary tract infection in mice, Infect. Immun. (1988)
56:947–953.
[17] Kirschner D., Marino S., Mycobacterium tuberculosis
as viewed through a computer, Trends Microbiol.
(2005) 13:206–211.
[18] Kornalijnslijper J.E., van Werven T., Daemen A.J.,
van den Broek J., Niewold T.A., Rutten V.P., Noordhuizen-
Stassen E.N., In vitro growth of mastitis-inducing
Escherichia coli in milk and milk fractions of dairy cows,
Vet. Microbiol. (2003) 91:125–134.
[19] Kornalijnslijper J.E., Daemen A.J., van Werven T.,
Niewold T.A., Rutten V.P., Noordhuizen-Stassen E.N.,
Bacterial growth during the early phase of infection
determines the severity of experimental Escherichia coli
mastitis in dairy cows,Vet. Microbiol. (2004) 101:177–186.
[20] Lohuis J.A., Schukken Y.H., Henricks P.A.,
Heyneman R., Burvenich C., Verheijden J.H., et al.,
Preinfection functions of blood polymorphonuclear
leukocytes and the outcome of experimental Escherichia
coli mastitis in the cow, J. Dairy Sci. (1990) 73:342–350.
[21] Mulvey M.A., Schilling J.D., Hultgren S.J., Establishment
of a persistent Escherichia coli reservoir during
the acute phase of a bladder infection, Infect. Immun.
(2001) 69:4572–4579.
[22] Olde Riekerink R.G., Barkema H.W., Kelton D.F.,
Scholl D.T., Incidence rate of clinical mastitis on
Canadian dairy farms, J. Dairy Sci. (2008) 91:1366–1377.
[23] Paape M., Mehrzad J., Zhao X., Detilleux J.,
Burvenich C., Defense of the bovine mammary gland by
polymorphonuclear neutrophil leukocytes, J. Mammary
Gland. Biol. Neoplasia (2002) 7:109–121.
[24] Saad A.M., Ostensson K., Flow cytofluorometric
studies on the alteration of leukocyte populations in blood
and milk during endotoxin-induced mastitis in cows, Am.
J. Vet. Res. (1990) 51:1603–1607.
[25] Schepers A.J., Lam T.J., Schukken Y.H.,
Wilmink J.B., Hanekamp W.J., Estimation of variance
components for somatic cell counts to determine thresholds
for uninfected quarters, J. Dairy Sci. (1997) 80:1833–
1840.
[26] Schukken Y.H., Grommers F.J., Vandegeer D.,
Brand A., Incidence of clinical mastitis on farms with
low somatic-cell counts in bulk milk, Vet. Rec. (1989)
125:60–63.
[27] VanWerven T., NoordhuizenStassen E.N.,
Daemen A.J., Schukken Y.H., Brand A., Burvenich C.,
Preinfection in vitro chemotaxis, phagocytosis, oxidative
burst, and expression of CD11/CD18 receptors and their
predictive capacity on the outcome of mastitis induced in
dairy cows with Escherichia coli, J. Dairy Sci. (1997)
80:67–74.
[28] Wearing H.J., Rohani P., Keeling M.J., Appropriate
models for the management of infectious diseases, PLoS
Med. (2005) 2:e174.
[29] Wilson D.J., Grohn Y.T., Bennett G.J., Gonza´lez
R.N., Schukken Y.H., Spatz J., Comparison of J5
vaccinates and controls for incidence, etiologic agent,
clinical severity, and survival in the herd following
naturally occurring cases of clinical mastitis, J. Dairy
Sci. (2007) 90:4282–4288.